3 Indian Growth Stocks With Earnings Growth Over 27%

High interest rates are pressuring many asset classes, yet AI spending on chips, data centers and power is still running hard, according to recent commentary on the US tech boom. That kind of relentless investment has investors hunting for Indian companies with strong earnings growth potential and solid balance sheets. This article walks through three stocks from a quality growth screener that fit that profile.

The three stocks highlighted here offer a compelling starting point if you want exposure to healthy high growth potential businesses with balance sheets that aim to keep risk in check. However, if you want the strongest names, these 45 best high growth potential stocks are at the top of the list.

Shaily Engineering Plastics (BSE:501423)

Shaily Engineering Plastics manufactures precision injection moulded components for healthcare, consumer and industrial uses, with its CDMO work and drug delivery devices for pharmaceutical customers anchoring its link to the Healthy high growth potential theme. It reports ₹10,246 million from customised components and carries a roughly ₹142.9b market cap.

For investors looking at healthcare linked earnings growth, Shaily Engineering Plastics offers a direct way to tap rising demand for complex drug delivery devices while still keeping exposure to broader plastic components.

"Although the GLP-1 opportunity is expanding rapidly worldwide and Shaily has onboarded a large roster of generic players across multiple countries, delays in regulatory approvals or slower than expected generic capture from innovators could cap utilization of its expanded pen capacity and temper healthcare revenue growth."

What happens if one quiet shift in how these therapies are delivered alters the pricing power the market is assuming today?

That pricing power debate is exactly what the full narrative for Shaily Engineering Plastics unpacks, highlighting where GLP-1 demand, capacity bets, and balance sheet strength could be quietly decoupling.

Timex Group India (BSE:500414)

Timex Group India designs, manufactures and sells branded watches across Timex and a roster of licensed luxury and consumer labels, giving it direct exposure to the Healthy high growth potential theme through its scalable watch franchise. It generates ₹8,486 million from watches and related service revenue and has a roughly ₹70.7b market cap.

Timex Group India ties neatly into this screener because analysts expect strong earnings growth over the next 3 years, underpinned by its expanding branded watch business and improving profit margins. Investors tracking this theme will likely watch how that earnings curve holds if a single pressure point on watch demand or pricing shifts.

If that pressure point is what you care about, go straight to the 2 key rewards and 1 important warning sign to see where expectations and reality might already be drifting.

Cemindia Projects (BSE:509496)

Cemindia Projects focuses on construction and civil engineering contracts in India, with its maritime and heavy concrete infrastructure work anchoring its link to the Healthy high growth potential theme.

Cemindia Projects earns all its ₹102,051 million revenue from construction contracts, primarily within India, and has a market value of roughly ₹205.7b.

For investors following this screener, Cemindia Projects matters because the heavy concrete work sitting inside its order book can translate directly into multi year earnings momentum if execution keeps pace with ambition.

"Although Cemindia Projects has a sizeable order backlog of around ₹31,000 crores, execution on large contracts such as Vadhvan Port and several newly awarded projects is still in early stages with work yet to start or only at design and mobilization, which could keep revenue recognition below what this backlog might imply if these delays extend or recur."

What happens if one quiet shift in how those largest projects are phased changes the cash conversion that current growth expectations depend on?

Those phasing risks are only half the story, and the full narrative for Cemindia Projects shows where Cemindia Projects' backlog, execution curve and cash generation could still accelerate.

Seeking Alternatives Before Momentum Flies

Fresh ideas move first. By the time every watchlist catches on, the easy part of the breakout is gone. Scan these under the radar lists while it matters and look for opportunities early.

• Identify cash rich balance sheets early and filter for resilient businesses through the list of solid balance sheet and fundamentals (203 results) before the market fully recognizes their momentum.
• Explore potential AI infrastructure spending and focus on suppliers in the 55 AI infrastructure stocks while many investors are still focused elsewhere.
• Target income streams that might help steady a portfolio and review the curated 214 dividend fortresses before yields potentially get compressed by later demand.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com